Clinical trial

Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease…

NCT00089141 · Martin, Paul, Other · Terminated

Key facts

NCT number NCT00089141
Title Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)
Official title A Randomized Study to Evaluate The Efficacy of Mycophenolate Mofetil Added to The Systemic Immunosuppressive Regimen First Used For Treatment of Chronic Graft-Versus-Host Disease
Lead sponsor Martin, Paul, Other
Collaborators National Cancer Institute (NCI) NIH
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Cancer
Intervention type Drug
Interventions mycophenolate mofetil, placebo
Enrollment 151
Start date May 1, 2004
Primary completion Jul 1, 2008
Completion Sep 1, 2008
First posted Aug 5, 2004
Last update posted May 3, 2013
Countries Canada, United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies